ALVR - AlloVir slips after multiple insider sales
2023-08-22 12:49:05 ET
More on AlloVir
- AlloVir: 'Takes One To Know One'
- AlloVir: Several Late-Stage Programs Make This Worth A Look
- AlloVir spikes as Bank of America starts at Buy on lead asset
- AlloVir spikes as Gilead buys over $10M stock
- AlloVir gains after long-term mortality data for lead asset
- Seeking Alpha’s Quant Rating on AlloVir
For further details see:
AlloVir slips after multiple insider sales